Loading live market data…

Day One Biopharmaceuticals, Inc.

NASDAQ:DAWN

$21.53 USD

$0 (0.0%)

Volume
0
Average Volume
4.01M
Market Capitalization
$2.22B
P/E Ratio
-20.70
Dividend Yield
0.00%
Price Target
$21.50
Year High
$21.53
Year Low
$5.64
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$8.02
Source Headline
Servier completes the acquisition of Day One Biopharmaceuticals

Acquisition expands Servier's position in oncology with tovorafenib marketed as OJEMDATM in the U.S . in pediatric low-grade glioma.

prnewswire.com - 2026-04-23 08:30:00

Get DAWN Insider Trade Alerts

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

DAWN Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$23.75

2 analysts

All Time

$35.17

9 analysts

DAWN Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-03-11 JP Morgan Downgrade Overweight Neutral
2026-03-10 HC Wainwright & Co. Downgrade Buy Neutral
2026-03-09 Wedbush Downgrade Outperform Neutral
2026-03-06 Jones Trading Downgrade Buy Hold
2026-03-06 Needham Downgrade Buy Hold
2026-02-25 HC Wainwright & Co. Maintain Buy Buy
2026-02-25 Wedbush Maintain Outperform Outperform
2026-02-25 Needham Maintain Buy Buy
2025-11-24 Needham Maintain Buy Buy
2025-11-24 HC Wainwright & Co. Maintain Buy Buy
2025-11-07 JP Morgan Maintain Overweight Overweight
2025-11-05 Piper Sandler Maintain Overweight Overweight
2025-08-06 Needham Maintain Buy Buy
2025-08-06 HC Wainwright & Co. Maintain Buy Buy
2025-05-07 Needham Maintain Buy Buy
2025-04-03 HC Wainwright & Co. Maintain Buy Buy
2025-03-25 Goldman Sachs Maintain Buy Buy
2025-03-05 JP Morgan Maintain Overweight Overweight
2025-02-26 Needham Maintain Buy Buy
2025-02-26 HC Wainwright & Co. Maintain Buy Buy
2025-02-26 Wedbush Maintain Outperform Outperform
2025-02-10 Goldman Sachs Maintain Buy Buy
2025-01-13 Needham Maintain Buy Buy
2025-01-07 B of A Securities Maintain Buy Buy
2024-12-17 Jones Trading Maintain Buy Buy
2024-10-31 Needham Maintain Buy Buy
2024-10-31 HC Wainwright & Co. Maintain Buy Buy
2024-10-09 Needham Maintain Buy Buy
2024-08-06 JP Morgan Maintain Overweight Overweight
2024-08-01 HC Wainwright & Co. Maintain Buy Buy
2024-08-01 B of A Securities Upgrade Underperform Buy
2024-08-01 HC Wainwright& Co. Maintain Buy Buy
2024-07-31 Needham Maintain Buy Buy
2024-07-30 Needham Maintain Buy Buy
2024-07-26 HC Wainwright & Co. Maintain Buy Buy
2024-07-08 Piper Sandler Maintain Overweight Overweight
2024-06-20 HC Wainwright & Co. Maintain Buy Buy
2024-06-19 Needham Maintain Buy Buy
2024-05-07 HC Wainwright & Co. Maintain Buy Buy
2024-05-07 Needham Maintain Buy Buy
2024-04-25 Needham Maintain Buy Buy
2024-04-24 HC Wainwright & Co. Maintain Buy Buy
2024-04-24 Needham Maintain Buy Buy
2024-04-22 JP Morgan Maintain Overweight Overweight
2024-03-26 Piper Sandler Maintain Overweight Overweight
2024-02-28 Piper Sandler Maintain Overweight Overweight
2024-02-27 Goldman Sachs Maintain Buy Buy
2024-02-27 Oppenheimer Maintain Perform Perform
2023-11-07 Needham Maintain Buy Buy
2023-11-07 Wedbush Maintain Outperform Outperform
2023-09-12 Needham Maintain Buy Buy
2023-09-12 Wedbush Maintain Outperform Outperform
2023-08-08 Goldman Sachs Maintain Buy Buy
2023-08-08 HC Wainwright & Co. Maintain Buy Buy
2023-06-05 HC Wainwright & Co. Maintain Buy Buy
2023-06-05 Wedbush Maintain Outperform Outperform
2023-06-05 Needham Maintain Buy Buy
2023-05-18 HC Wainwright & Co. Maintain Buy Buy
2023-05-08 Needham Maintain Buy Buy
2023-05-02 Needham Maintain Buy Buy
2023-04-25 B of A Securities Downgrade Buy Underperform
2023-04-05 Needham Maintain Buy Buy
2023-03-07 HC Wainwright & Co. Maintain Buy Buy
2023-03-07 Needham Maintain Buy Buy
2023-02-08 Capital One Maintain Overweight Overweight
2023-02-03 Oppenheimer Maintain Perform Perform
2023-01-09 Goldman Sachs Maintain Buy Buy
2023-01-09 HC Wainwright & Co. Maintain Buy Buy
2023-01-09 Piper Sandler Maintain Overweight Overweight
2022-12-15 HC Wainwright & Co. Maintain Buy Buy
2022-12-05 Goldman Sachs Maintain Buy Buy
2022-12-01 B of A Securities Maintain Buy Buy
2022-06-21 Piper Sandler Maintain Overweight Overweight
2022-06-14 Wedbush Maintain Outperform Outperform
2021-06-21 Wedbush Maintain Outperform Outperform
2021-06-21 Piper Sandler Maintain Overweight Overweight
2021-06-21 Cowen & Co. Maintain Outperform Outperform
2021-06-21 JP Morgan Maintain Overweight Overweight